Sputnik V, the vaccine developed by Russia’s Gamaleya National Center Covid, will be available in India from next week, the Union ministry of health and family welfare (MoHFW) announced on Thursday.
V K Paul, member (health) of the NITI Aayog, said on Thursday while addressing the press briefing: “I am very happy to say the limited supply that has come from Russia will start selling in India and more supplies will come in,” said Paul.
India is expecting 156 million doses of the vaccine from August to September.
Sputnik V, a vaccine with 91.6 per cent efficacy — the highest among Covid vaccines